Merck & Co., Inc. (N:MRK)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for MRK within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 24th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 13/20 Feb 13/20 Frazier Kenneth C Indirect Ownership Common Stock - 401(k) Plan Form 5 : Annual Statement of Beneficial Ownership of Securities    
Jan 15/20 Jan 13/20 Gerberding Julie L. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -33,012  
Jan 15/20 Jan 13/20 Gerberding Julie L. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -49,536  
Jan 15/20 Jan 13/20 Gerberding Julie L. Direct Ownership Common Stock S - Open market or private sale -102,073 $89.34
Jan 15/20 Jan 13/20 Gerberding Julie L. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 33,012  
Jan 15/20 Jan 13/20 Gerberding Julie L. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 49,536  
Jan 3/20 Dec 31/19 Weeks Wendell P Direct Ownership Phantom Stock A - Grant, award or other under Rule 16b-3(d) 316 $90.95
Jan 3/20 Dec 31/19 Lazarus Rochelle B Direct Ownership Phantom Stock A - Grant, award or other under Rule 16b-3(d) 316 $90.95
Jan 3/20 Dec 31/19 Coe Mary Ellen Direct Ownership Phantom Stock A - Grant, award or other under Rule 16b-3(d) 344 $90.95
Feb 13/20 Nov 12/19 Frazier Kenneth C Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -118,764  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for MRK within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 24th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 13/20 Feb 13/20 Frazier Kenneth C Indirect Ownership Common Stock - 401(k) Plan Form 5 : Annual Statement of Beneficial Ownership of Securities    
Feb 13/20 Nov 12/19 Frazier Kenneth C Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -118,764  
Jan 15/20 Jan 13/20 Gerberding Julie L. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -33,012  
Jan 15/20 Jan 13/20 Gerberding Julie L. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -49,536  
Jan 15/20 Jan 13/20 Gerberding Julie L. Direct Ownership Common Stock S - Open market or private sale -102,073 $89.34
Jan 15/20 Jan 13/20 Gerberding Julie L. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 33,012  
Jan 15/20 Jan 13/20 Gerberding Julie L. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 49,536  
Jan 3/20 Dec 31/19 Weeks Wendell P Direct Ownership Phantom Stock A - Grant, award or other under Rule 16b-3(d) 316 $90.95
Jan 3/20 Dec 31/19 Lazarus Rochelle B Direct Ownership Phantom Stock A - Grant, award or other under Rule 16b-3(d) 316 $90.95
Jan 3/20 Dec 31/19 Coe Mary Ellen Direct Ownership Phantom Stock A - Grant, award or other under Rule 16b-3(d) 344 $90.95
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $MRK

Competitors

Competitors with Recent Insider Filings
Horizon Therapeutics PLC (OQ:HZNP)
BridgeBio Pharma (OQ:BBIO)
Arvinas (OQ:ARVN)